What question did this study set out to answer?

This research aims to evaluate the role of prostate-specific antigen density in predicting prostate cancer aggressiveness and biopsy outcomes.

March 10, 20260 citations

View Full Paper

Evaluation of the association between prostate-specific antigen density and systematic prostate biopsy pathological results.

CBCoşkun BostancıMinistry of Health KEKazım ErdemMinistry of Health

Key Points

This research aims to evaluate the role of prostate-specific antigen density in predicting prostate cancer aggressiveness and biopsy outcomes.
Utilized prostate-specific antigen density as a marker in assessing biopsy results.
Analyzed the correlation between PSA density and prostate cancer aggressiveness.
Considered the effectiveness of PSA density in clinical decision-making for diagnosis.
PSA density demonstrated a higher diagnostic accuracy compared to traditional PSA.
The incorporation of PSA density improved the likelihood of identifying clinically significant prostate cancer.

Abstract

PSA-d is a reliable marker for predicting PCa aggressiveness and has better diagnostic accuracy than PSA. Incorporating PSA-d into clinical decision-making may enhance the detection of clinically significant PCa, particularly in resource-limited settings where advanced imaging modalities are unavailable.

Demander à l'IA

Bookmark

View Full Paper

Demander à l'IA

Bookmark

View Full Paper

Evaluation of the association between prostate-specific antigen density and systematic prostate biopsy pathological results.

Key Points

Abstract

Cite This Study